FI964783L - Method for treating cancer by regulating p53 protein - Google Patents
Method for treating cancer by regulating p53 protein Download PDFInfo
- Publication number
- FI964783L FI964783L FI964783A FI964783A FI964783L FI 964783 L FI964783 L FI 964783L FI 964783 A FI964783 A FI 964783A FI 964783 A FI964783 A FI 964783A FI 964783 L FI964783 L FI 964783L
- Authority
- FI
- Finland
- Prior art keywords
- protein
- regulating
- treating cancer
- cancer
- treating
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9406583 | 1994-05-31 | ||
FR9406583A FR2720277B1 (en) | 1994-05-31 | 1994-05-31 | Method of treating cancer by regulating the P53 protein. |
FR9500670 | 1995-05-22 | ||
PCT/FR1995/000670 WO1995033060A1 (en) | 1994-05-31 | 1995-05-22 | Method of cancer treatment by p53 protein control |
Publications (3)
Publication Number | Publication Date |
---|---|
FI964783A0 FI964783A0 (en) | 1996-11-29 |
FI964783L true FI964783L (en) | 1996-11-29 |
FI120501B FI120501B (en) | 2009-11-13 |
Family
ID=9463670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI964783A FI120501B (en) | 1994-05-31 | 1996-11-29 | Use of inhibitors of calpain activity, which regulate the level of p53 protein in the manufacture of anti-cancer drugs |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0763121A1 (en) |
JP (1) | JPH10500978A (en) |
AU (1) | AU714209B2 (en) |
CA (1) | CA2190293C (en) |
FI (1) | FI120501B (en) |
FR (1) | FR2720277B1 (en) |
NO (1) | NO321411B1 (en) |
WO (1) | WO1995033060A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19518488C1 (en) * | 1995-05-19 | 1996-10-10 | Progen Biotechnik Gmbh | Autoantigen, suitable for determining a tendency to thrombosis |
EP0799892A3 (en) * | 1996-04-05 | 1998-08-12 | Takeda Chemical Industries, Ltd. | Calpain, its production and use |
US6232454B1 (en) | 1998-02-27 | 2001-05-15 | Incyte Genomics, Inc. | Human proteinase molecules |
AU2344100A (en) * | 1998-11-18 | 2000-06-05 | Canji, Inc. | Viral vectors with late transgene expression |
AU2001247922A1 (en) * | 2000-03-31 | 2001-10-15 | Parker Hughes Institute | Calpain inhibitors in cancer treatment |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0753665B2 (en) * | 1984-04-20 | 1995-06-07 | 財団法人癌研究会 | Anti-metastatic agent |
US5340922B1 (en) * | 1988-05-31 | 1999-11-02 | Mclean Hospital Corp | Neural calcium-activated neutral proteinase inhibitors |
EP0395309B1 (en) * | 1989-04-28 | 1995-12-27 | Takara Shuzo Co. Ltd. | Human calpastatin-like polypeptide |
JPH0641067A (en) * | 1992-04-20 | 1994-02-15 | Kitasato Inst:The | New calpain-inhibitor kp-1241 and its production |
EP0580161A1 (en) * | 1992-07-22 | 1994-01-26 | THE McLEAN HOSPITAL CORPORATION | Prophylactic and therapeutic treatment of Alzheimer's disease |
US5607831A (en) * | 1993-03-25 | 1997-03-04 | The United States Of America As Represented By The Department Of Health And Human Services | In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death |
-
1994
- 1994-05-31 FR FR9406583A patent/FR2720277B1/en not_active Expired - Lifetime
-
1995
- 1995-05-22 AU AU26206/95A patent/AU714209B2/en not_active Ceased
- 1995-05-22 JP JP8500420A patent/JPH10500978A/en active Pending
- 1995-05-22 EP EP95920973A patent/EP0763121A1/en not_active Withdrawn
- 1995-05-22 WO PCT/FR1995/000670 patent/WO1995033060A1/en not_active Application Discontinuation
- 1995-05-22 CA CA2190293A patent/CA2190293C/en not_active Expired - Fee Related
-
1996
- 1996-11-11 NO NO19964772A patent/NO321411B1/en not_active IP Right Cessation
- 1996-11-29 FI FI964783A patent/FI120501B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI120501B (en) | 2009-11-13 |
FI964783A0 (en) | 1996-11-29 |
FR2720277A1 (en) | 1995-12-01 |
EP0763121A1 (en) | 1997-03-19 |
CA2190293C (en) | 2011-06-28 |
AU714209B2 (en) | 1999-12-23 |
WO1995033060A1 (en) | 1995-12-07 |
CA2190293A1 (en) | 1995-12-07 |
NO321411B1 (en) | 2006-05-08 |
JPH10500978A (en) | 1998-01-27 |
FR2720277B1 (en) | 1996-07-12 |
NO964772L (en) | 1996-11-11 |
NO964772D0 (en) | 1996-11-11 |
AU2620695A (en) | 1995-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI971568L (en) | Method for treating resistant tumors | |
FI970918L (en) | Compounds and methods for treating cancer | |
FI970102L (en) | Method for synthesizing substituted sulfoxides | |
FI970059L (en) | Method for regulating immune function | |
FI951702L (en) | Pharmaceutical method for treating osteoporosis | |
FI935922L (en) | Method for treating wastewater | |
SG50018A1 (en) | Method for developing treatment | |
AU4017395A (en) | Method for treating anxiety | |
KR970001365A (en) | Method for preparing alkylhydrogenchlorosilane | |
FI973133L (en) | Method for treating wastewater, substance therefor and method for preparing the substance | |
LV11745A (en) | Method for continuous varisan wheat | |
FI20050181L (en) | Method for preparing 21-chlorocorticosteroids | |
NO950656D0 (en) | Process for treating oily formation | |
FI964821L (en) | Method for preparing improved biological pesticides | |
FI960658L (en) | New bis-naphthalimides for cancer treatment | |
FI963598L (en) | Immunotherapeutic method for treating cancer diseases by administering gamma globulins | |
FI973469L (en) | Method for preparing factor IX from biological sources | |
ID18055A (en) | METHOD FOR TREATING MOLD GOODS | |
FI973173L (en) | Method for treating condensate | |
FI964783L (en) | Method for treating cancer by regulating p53 protein | |
BR9408521A (en) | Method for synthesizing gamma-pyrones | |
FI945877L (en) | Method for producing protein C | |
FI964410L (en) | Process for preparing 4-amino-delta4-3-ketosteroids via 4-nitro-delta4-3-ketosteroids | |
FI962882L (en) | Method for preparing reduced metal-titanium complexes | |
FI950044L (en) | Method for inhibiting protein C degradation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: AVENTIS PHARMA S.A. |
|
FG | Patent granted |
Ref document number: 120501 Country of ref document: FI |
|
MM | Patent lapsed |